课题基金 / 基金详情

Regulation and function of cytoskeleton reorganization by signaling molecules in hematopoietic cells.

Regulation and function of cytoskeleton reorganization by signaling molecules in hematopoietic cells.
造血细胞中信号分子对细胞骨架重组的调节和功能。
批准号:
17590437
负责人:
TANAKA Yoshihiko
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

TANAKA Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cytoskeleton reorganization regulates cell polarity, migration and signal transduction in various cells, but the precise role in hematopoietic cells is still unclear. In this study, we focused on several aspects of the regulation and function of cytoskeleton reorganization molecules, such as DOCK2,Vavl, and SLAT, in hematopoietic cell activation. We found that DOCK2 deficiency causes marked reduction of Val4 NKT cells in the thymus, liver, and spleen. Studies using bone marrow chimeras indicated that development of Val4 NKT cell requires DOCK2 expression in T cell precursors, but not in APCs. We also reported that DOCK2 regulates motility and polarity during neutrophil chemotaxis. In DOCK2-deficient neutrophils, chemoattractant-induced activation of both Rac1 and Rac2 were severely impaired, resulting in the loss of polarized accumulation of F-actin and phosphatidylinositol 3,4,5-triphosphate (PIP_3) at the leading edge. These results indicate that during neutrophil chemotaxis DOCK2 regulates leading edge formation through PIP_3-dependent membrane translocation and Rac activation. In addition, we showed that Vavl is selectively required for IL-4 and c-Maf expression, a requirement reflecting, at least in part, the dependence of c-Maf expression of Ca^<2+>/NFAT signaling. Finally, we found that SLAT regulates Th1 and Th2 lung inflammatory responses by controlling Ca^<2+>/NFAT signaling. Thus, we demonstrated several critical aspects for cytoskeleton reorganization in hematopoietic cells using a combination of biochemical and genetic approaches. Future work should be aimed at defining the precise mechanisms through which these molecules regulate the function of cytoskeleton reorganization.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
リンパ球の運動性を制御する分子DOCK2
DOCK2,一种控制淋巴细胞运动的分子
DOI: --
发表时间: 2005
期刊: 医学のあゆみ 213
影响因子: --
作者: [岡崎 拓, 本庶 佑, 周岡 拓, Nombela-Arrieta C et al., Handa Y et al., Nombela-Arrieta C et al., Handa Y et al., Nombela-Arrieta C et al., Handa Y et al., Gercia-Bernal D et al., Kunisaki Y et al., Shulman Z et al., Kunisaki Y et al., 福井宣規, Garcia-Bernal D et al., Shulman Z et al., Kunisaki Y et al., Fukui Y., Garcia-Bernal D et al., Kunisaki Y et al., Kunisaki Y et al., Jiang H et al., 福井宣規]
通讯作者: 福井宣規
DOCK2 is required for chemokine-promoted human T lymhocyte adhesion under shear stress mediated by the integnin α4β1.
在整合素 α4β1 介导的剪切应力下,趋化因子促进人 T 淋巴细胞粘附需要 DOCK2。
DOI: --
发表时间: 2006
期刊: J.Immunol. 177
影响因子: --
作者: [Garcia-Betnal, D. et al.]
通讯作者: D. et al.
Impaired IL-4 and c-Maf expression and enhanced Thl cell development in Vavl-deficient mice.
Vavl 缺陷小鼠中 IL-4 和 c-Maf 表达受损,Thl 细胞发育增强。
DOI: --
发表时间: 2005
期刊: Blood 106
影响因子: --
作者: [Tanaka, Y. et al.]
通讯作者: Y. et al.
DOI: 10.1084/jem.20050911
发表时间: 2005-10-17
期刊: JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 15.3
作者: [Jiang, HS, Erickson, LM, Fukui, Y]
通讯作者: Fukui, Y
21
    Molecular mechanism of lymphocyte activation by a novel CDM-family protein.
    • 批准号:
      21590537
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      TANAKA Yoshihiko
    • 依托单位:
    DOCK2 regulates allergic disease through a mechanism dependent onCD4^+ T cells
    • 批准号:
      19590497
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      TANAKA Yoshihiko
    • 依托单位:
    国内基金
    海外基金
    Cellular & Molecular Immunology
    • 批准号:
      30824806
    • 项目类别:
      专项基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2008
    • 负责人:
      魏海明
    • 依托单位: